The NM_000070.3: c.1076C>T variant in CAPN3 is a missense variant predicted to cause substitution of proline by leucine at amino acid 359 (p.Pro359Leu). This variant has been reported in at least 8 patients with clinical signs of LGMD, including in a homozygous state in at least 6 individuals (1.0 pt; PMID: 22926650, 17596655, 30564623; ClinVar SCV001524377.1, SCV001544778.3 internal data communication; LOVD CAPN3_000128) and in unconfirmed phase with a likely pathogenic variant in at least one individual (c.1256A>G p.(Asp419Gly), 0.25 pts, PMID: 30564623, LOVD Individual #00220445, GRASP-LGMD Consortium internal data communication) (PM3). At least one patient homozygous for this variant displayed progressive limb girdle muscle weakness and absent expression of calpain-3 in skeletal muscle, which is highly specific for CAPN3-related LGMD (PMID: 17596655; PP4_Strong). The highest population minor allele frequency in gnomAD v4.1.1 is 0.00001648 (1/60664 alleles) in the Remaining population, which is lower than the ClinGen LGMD VCEP threshold (<0.0001) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.955, which is above the threshold of 0.70, evidence that correlates with impact to CAPN3 function (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (specifications v2.0.0; 04/28/2026): PM3, PP4_Strong, PM2_Supporting, PP3.